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Abstract
Background: Intranasal oxytocin (OT) has been shown to improve social communication functioning of individuals
with autism spectrum disorder (ASD) and, thus, has received considerable interest as a potential ASD therapeutic
agent. Although preclinical research indicates that OT modulates the functional output of the mesocorticolimbic
dopamine system that processes rewards, no clinical brain imaging study to date has examined the effects of OT
on this system using a reward processing paradigm. To address this, we used an incentive delay task to examine
the effects of a single dose of intranasal OT, versus placebo (PLC), on neural responses to social and nonsocial
rewards in children with ASD.
Methods: In this placebo-controlled double-blind study, 28 children and adolescents with ASD (age: M = 13.43 years,
SD = 2.36) completed two fMRI scans, one after intranasal OT administration and one after PLC administration. During
both scanning sessions, participants completed social and nonsocial incentive delay tasks. Task-based neural activation
and connectivity were examined to assess the impact of OT relative to PLC on mesocorticolimbic brain responses to
social and nonsocial reward anticipation and outcomes.
Results: Central analyses compared the OT and PLC conditions. During nonsocial reward anticipation, there was
greater activation in the right nucleus accumbens (NAcc), left anterior cingulate cortex (ACC), bilateral orbital frontal
cortex (OFC), left superior frontal cortex, and right frontal pole (FP) during the OT condition relative to PLC.
Alternatively, during social reward anticipation and outcomes, there were no significant increases in brain activation
during the OT condition relative to PLC. A Treatment Group × Reward Condition interaction revealed relatively greater
activation in the right NAcc, right caudate nucleus, left ACC, and right OFC during nonsocial relative to social reward
anticipation during the OT condition relative to PLC. Additionally, these analyses revealed greater activation during
nonsocial reward outcomes during the OT condition relative to PLC in the right OFC and left FP. Finally, functional
connectivity analyses generally revealed changes in frontostriatal connections during the OT condition relative to PLC
in response to nonsocial, but not social, rewards.
Conclusions: The effects of intranasal OT administration on mesocorticolimbic brain systems that process rewards in
ASD were observable primarily during the processing of nonsocial incentive salience stimuli. These findings have
implications for understanding the effects of OT on neural systems that process rewards, as well as for experimental
trials of novel ASD treatments developed to ameliorate social communication impairments in ASD.
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Background
Autism spectrum disorder (ASD) is a neurodevelopmental
disorder characterized by impairments in social communi-
cation and interaction, as well as restricted and repetitive
behaviors (APA [1]). Although various pharmacological
treatments are commonly prescribed to treat associated
symptoms of ASD (e.g., irritability, inattention, and aggres-
sion), there are currently no pharmacological treatments
approved to treat the core features of the disorder [2–4].
The neuropeptide oxytocin (OT) has been shown to in-
crease pro-social behaviors in human studies and in pre-
clinical model organisms. Studies in typically developing
individuals have shown that intranasal OT administration
increases in-group trust [5] and interoceptive awareness
[6] while also reducing fear [7]. Preclinical studies, on the
other hand, have established the vital role of OT in social-
ity. For example, in mammalian nonhuman models, OT
moderates or initiates paternal and reproductive behav-
iors, as well as other pro-social behaviors such as groom-
ing and social recognition [8, 9].
Because of the need for effective treatments for core
ASD symptoms, there has been increasing interest in the
potential for OT to ameliorate social communication
impairments in ASD. Some, but not all, studies of the ef-
fects of OT in ASD have reported benefits in social
functioning, including enhanced emotion recognition
[10], increased eye gaze [11], and enhanced feelings of
trust in others [12]. Other studies, however, have failed
to find clinical benefits of OT on primary social out-
come measures [13, 14], and a recent trial found that
the beneficial effects of OT on social functioning in ASD
were moderated by pre-treatment endogenous OT
levels, suggesting that OT may be beneficial for some,
but not all, individuals with ASD [15].
Although there is emerging evidence that OT may be
clinically beneficial for at least a significant subset of in-
dividuals with ASD, the mechanisms of action of OT are
not well understood. One potential mechanism of action
may be the capacity of OT to modulate sensitivity to,
and the perceived salience of, external rewards that in-
fluence behavior and facilitate reward-based learning.
Preclinical studies implicate the mesocorticolimbic
dopamine system as a mechanism by which OT exerts
its pro-social effects [16, 17]. This neural network is com-
prised of midbrain structures (the ventral tegmental area
(VTA) and substantia nigra), the striatum, and cortical re-
gions including the orbital frontal, anterior cingulate, and
prefrontal cortices [18]. OT and mesocorticolimbic dopa-
mine interact in such a manner that the activation of OT-
responsive neurons in the VTA increases dopaminergic
activity in the broader mesocorticolimbic system [19–21].
Furthermore, when administered an OT receptor agonist,
mice demonstrate a subsequent decrease in dopaminergic
release within the nucleus accumbens, reflecting the
influence of OT on mesocorticolimbic dopamine trans-
mission [19].
To date, no functional neuroimaging study has exam-
ined the effects of OT on the mesocorticolimbic system
in response to rewards in ASD. However, two functional
neuroimaging studies indicate the relevance of mesocor-
ticolimbic brain regions to the potential mechanisms of
action of OT in ASD. Gordon et al. [22] found increased
activation in the ventral striatum, left posterior superior
temporal sulcus, and left premotor cortex in ASD in re-
sponse to acute intranasal OT administration during a
socio-emotional recognition task and that these same
brain regions showed decreased activation to nonsocial
(i.e., object) judgements. Other research from this group
found that intranasal OT administration increased func-
tional connectivity between the ventral striatum and
ventromedial prefrontal cortex in ASD in response to a
biological motion task, underscoring the potential
centrality of mesocorticolimbic brain regions to the
mechanism of action of OT [23].
Although both of these studies highlight the potential
relevance of reward-responsive mesocorticolimbic brain
regions to the mechanism of action of OT in ASD, nei-
ther used a reward task to directly test this hypothesis.
Thus, the goal of the present study was to extend these
findings by assessing the impact of acute intranasal OT
administration on response to rewards in ASD using
social and nonsocial incentive delay tasks. Social and
nonsocial incentive delay tasks have been used in mul-
tiple studies to investigate reward processing in ASD
(for a review see [24]). These studies have consistently
revealed reduced ventral striatal activation during social
and nonsocial reward anticipation in ASD [25–28].
Although the pattern of mesocorticolimbic responses to
rewards in ASD is complex (i.e., different studies with
different sample characteristics have reported decreased
ventral striatal responses to social, but not nonsocial, re-
ward anticipation in ASD [27, 29] whereas others have
reported decreased ventral striatal responses to nonso-
cial, but not social, reward anticipation in ASD [26]), it
is clear that mesocorticolimbic responses to rewards in
ASD are impaired and that incentive tasks are suitable
to study the functional integrity of this system.
Participants in the current study completed functional
neuroimaging scans after double-blind administration of
OT or PLC, and responses to nonsocial and social rewards
were examined. We hypothesized that intranasal OT
administration, relative to PLC, would result in greater ac-
tivation and connectivity within mesocorticolimbic brain
regions (frontal lobes, amygdala, nucleus accumbens
(NAcc), insula, thalamus, caudate nucleus, anterior cingu-
late cortex (ACC), and putamen) that have previously
been found to be functionally impaired during reward
processing in ASD [30]. We also hypothesized that the
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effects of OT would be more pronounced in the social,
relative to nonsocial, reward context because of the puta-
tive pro-social effects of OT described earlier [22, 23]. Fi-
nally, we explored relations between neural response to
OT, symptom severity, and salivary OTconcentrations.
Methods
Participants
This protocol was approved by the Institutional Review
Boards at the University of North Carolina at Chapel
Hill and Duke University Medical Center, and informed
consent was obtained from the parent or guardian of
each participant before testing. Participants older than
11 also provided verbal and written assent. Participants
were recruited through the Autism Research Registry
maintained through the Carolina Institute for Developmental
Disabilities. Exclusion criteria included a history of medical
conditions associated with ASD, including Fragile X
syndrome, tuberous sclerosis, neuro-fibromatosis, phenylke-
tonuria, epilepsy and traumatic brain injury, full-scale
intelligence < 70, and MRI contraindications.
The study enrolled 33 children and adolescents with ASD
ages 10 to 17 years old. Diagnoses were based on a history of
clinical diagnosis confirmed by proband assessment by a re-
search reliable assessor via Module 3 or 4 of the Autism
Diagnostic Observation Schedule, Second Edition (ADOS-2;
[31]) using standard clinical algorithm cutoffs. Of the 33 in-
dividuals enrolled, data from 28 were analyzable (see Table 1):
one participant elected to discontinue testing during the first
visit, another was unable to complete the scan due to claus-
trophobia, and three participants were excluded due to ex-
cessive motion (see “Motion Correction” for details).
After providing informed consent, participants com-
pleted two fMRI sessions (one after OT administration
and one after PLC administration, with the order of
scans counter-balanced across participants). The two
scan sessions were scheduled at least 72 h apart to
minimize the possibility of carry-over effects of OT
administration (mean time between scans = 15 days;
range = 3–46 days). Participants were offered the oppor-
tunity to participate in an optional mock scan prior to
the neuroimaging sessions. Families were compensated
$50 for each visit attended.
Drug protocol
Oxytocin (Syntocinon®, Novartis, Switzerland) and a
matched solution containing no medication (PLC) were
repackaged into identically appearing bottles. The
administration sequence was counter-balanced by UNC
Investigational Drug Service and Triangle Compounding
Pharmacy, and OT and PLC were administered to partic-
ipants by a blinded research assistant. A 24 international
unit (IU)/mL dose of each solution was administered in
alternating nostril insufflations (six total puffs) over the
course of several minutes. This dose was the same as
those used in multiple previous studies examining the
effect of OT in adults, adolescents, and children with
ASD [10, 11, 14, 22, 23]. Recent clinical and preclinical
findings have demonstrated intranasal OT’s ability to
increase peripheral (i.e., cerebrospinal fluid, plasma) OT
concentrations [32], while preclinical research has re-
ported augmented brain OT levels following intranasal
OT administration [33–35].
fMRI task
As described in Richey et al., participants completed two
versions of an incentive delay tasks [36] such that nonso-
cial rewards (i.e., money) and social rewards (i.e., pictures
of smiling faces) were presented as rewards on alternating
runs. Participants were presented with two runs of the
nonsocial reward condition and two runs of the social re-
ward condition. On all runs, rewards could be won or not
won (i.e., there was no “loss” condition). Face stimuli were
smiling images from the NimStim set of facial expressions
[37]. Each run began with a 10-s instructional screen indi-
cating the forthcoming reward type (i.e., nonsocial or so-
cial), and the two task types were segregated by run to
minimize the number of cues to be memorized.
Each trial consisted of (1) a 2000-ms cue indicating
whether adequately quick responses to the bull’s-eye
would result in a “win” (a triangle) or not (a circle); (2) a
2000–2500-ms crosshair fixation; (3) a target bull’s-eye
presented for up to 500 ms that requires a speeded but-
ton press; (4) 3000 ms of feedback that indicated
whether that trial was a “win” or not, with wins accom-
panied by either an image of money or a face; and (5) a
variable length ITI crosshair resulting in a total trial dur-
ation of 12 s. Potential win and non-win trials were
aperiodic and pseudorandomly ordered. Each 8-min run
contained 40 trails, half of which were potential win tri-
als. The task was adaptive such that participants were
successful on two thirds of trials, regardless of individual
differences in RTs (confirmed via inspection of behav-
ioral data collected during scanning). Mean reaction
times were calculated during practice trials prior to the
scan and then entered into the fMRI paradigm to ensure
that participants succeeded on 66% of their responses as
described in [36].
Table 1 Participant characteristics
Characteristic Mean Standard deviation Range
Age 13.43 2.36 10–17
Full-scale IQ 103.55 15.19 75–128
ADOS-2 calibrated severity score 8.46 1.29 7–10
SRS total T score 76.19 10.66 49–90
Sex 26 males, 2 females
ADOS-2 calibrated severity scores were calculated for modules 3 and 4 using
guidelines established by Gotham et al. [83] and Hus and Lord [84]
ADOS-2 Autism Diagnostic Observation Schedule, Second Edition
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During nonsocial runs, participants won $1 per trial if
bull’s-eye responses were adequately quick. During social
runs, participants viewed a face image if bull’s-eye re-
sponses were adequately quick. Coincident with feed-
back, cumulative win totals were presented. Participants
were instructed to respond to all target bull’s-eyes as
quickly as possible to win on as many trials as possible
and win or non-win outcomes were contingent on reac-
tion times (RTs). Standard administration of incentive
delay tasks involves showing participants’ rewards that
may be won prior to scanning [36]. Consistent with this
procedure, participants were shown the money they
could win based on scanner task performance and were
informed that they would receive the total amount of
money won during the scan. Prior to scanning, partici-
pants rated face stimuli on the dimensions of valence
and arousal. Stimuli were presented using E-Prime pres-
entation software version 2.0 (Psychology Software Tools
Inc., Pittsburgh, PA, USA).
Prior to and immediately following each scan, partici-
pants were asked to rate face stimuli on the dimensions
of valence, arousal, and trust using Qualtrics software
(Qualtrics, Provo, UT) on a computer outside of the
scanner (pre-scan ratings were completed prior to the
nasal spray administration).
Imaging methods and preprocessing
Functional imaging data were acquired at the Duke-
UNC Brain Imaging and Analysis Center (BIAC) on a
3.0-T General Electric (Waukesha, WI, USA) MR750
scanner system equipped with 50 mT/m gradients and
an eight-channel head coil. High-resolution T1-weighted
anatomical images were acquired with 256 axial slices
using an FSPGR pulse sequence (TR = 8.16 ms, TE =
3.18 ms; flip angle = 12°; FOV = 256; image matrix =
256 mm2; voxel size = 1 × 1 × 1 mm) for normalization
and co-registration. Whole brain functional images were
acquired with 64 axial slices oriented parallel to the AC-
PC plane using a spiral-in SENSE sequence (TR =
1500 ms, TE = 30 ms; flip angle = 60°; FOV = 240; image
matrix = 64 mm2; voxel size = 3.75 × 3.75 × 4 mm). The
first four volumes of each functional task were discarded
to allow for steady state equilibrium.
Functional data were preprocessed using FSL version
5.0.1 (Oxford Centre for Functional Magnetic Resonance
Imaging of the Brain (FMRIB), Oxford University, UK).
Preprocessing was applied as follows: (1) brain extrac-
tion for non-brain removal [38], (2) motion correction
using MCFLIRT [39], (3) spatial smoothing using a
Gaussian kernel of FWHM 5 mm, (4) mean-based inten-
sity normalization of all volumes by the same factor, and
(5) high-pass filtering [40]. Functional images were co-
registered to structural images in native space, and
structural images were normalized into a standard
stereotaxic space (Montreal Neurological Institute). Reg-
istrations used an intermodal registration tool [38, 40].
Voxel-wise temporal autocorrelation was estimated and
corrected using FMRIB’s Improved Linear Model [41].
Motion correction
Consistent with motion thresholds used in Gordon et al.
[22], runs with maximum motion > 3 mm along any of
six axes (i.e., x, y, z, pitch, yaw, and roll) were excluded
from analyses. Due to excessive motion (> 3 mm), some
participants only had one social and/or nonsocial reward
condition run per scan. Participants were only included
in the final analyses if they had at least one nonsocial
and one social run that met motion criteria for both
their OT and PLC scans. Either due to motion or the
participant’s ability to stay in the scanner for the entire
length of the scan, 17 of the 56 scans had less than four
total runs. Sixty-six percent of runs included in analyses
had < 1.0 mm of motion in any axis (pitch, roll, yaw, x,
y, z), 26% had 1.0–1.99 mm of motion, and 8% had
motion between 2.0 and 2.9 mm. In addition to conduct-
ing motion correction using MCFLIRT [39], time points
with large motion, as defined by FSL, were entered into
the general linear model (GLM) model as additional con-
found variables within first-level analyses using FSL’s
motion outlier detection program (http://fsl.fmrib.ox.-
ac.uk/fsl/fslwiki/FSLMotionOutliers). Following motion
correction, paired t tests were used to compare differ-
ences in motion between OT and PLC groups: there
was equivalent motion for mean and maximum values
along all six axes (i.e., x, y, z, pitch, yaw, and roll), all
p values > .05.
fMRI analysis
Planned analyses included (1) treatment group (OT vs.
PLC) differences in frontostriatal functional activation
and connectivity in response to social reward anticipa-
tion and outcomes; (2) treatment group differences in
frontostriatal functional activation and connectivity in
response to nonsocial reward anticipation and outcomes;
(3) treatment group differences in frontostriatal func-
tional activation in response to nonsocial relative to so-
cial reward anticipation and outcomes, conducted also
with a small volume correction for the striatum alone
given the centrality of this region for reward processing;
and (4) correlations between frontostriatal functional
activation and connectivity with ASD symptoms and sal-
ivary OT analyses.
Supplemental analyses included (1) main effects of OT
and PLC separately on whole brain functional activation
in response to nonsocial and social reward anticipation
and outcomes, (2) treatment group (OT vs. PLC) differ-
ences in frontostriatal structural activation in response to
social and nonsocial reward anticipation and outcomes,
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(3) correlations between structural activation with ASD
symptoms, and (4) treatment group differences in frontos-
triatal functional connectivity of structurally defined clus-
ters in response to social and nonsocial reward
anticipation and outcomes.
Small volume corrections
For all analyses, anticipation and outcome phases were an-
alyzed separately. Key anatomical regions within the re-
ward system (superior frontal gyrus, medial frontal gyrus,
orbitofrontal gyrus, paracingulate gyrus, amygdala, nu-
cleus accumbens (NAcc), insula, thalamus, caudate nu-
cleus, anterior cingulate cortex (ACC), and putamen)
were defined a priori for small volume correction. These
regions were generated separately for the right and left
hemispheres in FSL using the Harvard–Oxford cortical
and subcortical structural probabilistic atlases. Masks
were thresholded at 25%, binarized, and then combined
into a single mask using fslmaths. For planned main effect
analyses (i.e., nonsocial and social reward conditions
analyzed independently) and planned interaction ana-
lyses (i.e., nonsocial > social, social > nonsocial), vox-
els were considered significant if they passed a
threshold of p < .005 and were part of a 39-voxel clus-
ter of contiguous significant voxels, resulting in a
cluster-corrected p < .05. This cluster size was deter-
mined by performing 1000 Monte Carlo simulations
using 3dClustSim [42]. Interaction analyses (e.g., non-
social > social) also included an analysis using a small
volume correction that included only the striatum
given our a priori interest in the striatum. Due to this
small volume correction, interaction clusters within the stri-
atum were considered significant if they passed a statistical
threshold of p < .005 and were part of a 17-voxel cluster of
contiguous significant voxels, resulting in a cluster-corrected
threshold of p < .05 (again determined by performing 1000
Monte Carlo simulations using 3dClustSim [42]). Localiza-
tions were based on Harvard–Oxford cortical and subcor-
tical structural probabilistic atlases as implemented in
FSLView version 5.0.1, and all activations were visualized
with MRIcron (https://www.nitrc.org/projects/mricron/).
Activation analyses
Whole brain general linear model (GLM) activation ana-
lyses were conducted using the FSL expert analysis tool
(FEAT). For ROI analyses, each participant’s condition-
specific mean percent signal change was calculated for
both the social and nonsocial conditions. Within-
participant activation differences were analyzed for treat-
ment effects using paired t tests and using a 2 (Treatment
Group: OT, PLC) × 2 (Reward Condition: nonsocial,
social) ANOVA (see Additional file 1: Supplementary
Materials). Structural ROI activation results are also
provided in Additional file 1: Supplementary Materials.
Connectivity analyses
Task-based functional connectivity was analyzed using a
generalized psychophysiological interaction (gPPI)
approach due to its improved power, sensitivity, and spe-
cificity in detecting context-dependent functional con-
nectivity [43, 44]. Functional seeds were derived from
activation clusters showing significant OT > PLC effects.
These seeds were supplemented with structural left and
right NAcc seeds because of the centrality of the NAcc
to the mesocorticolimbic reward processing system [36],
once again defined using the Harvard–Oxford subcor-
tical structural probabilistic atlas. Voxel-wise models
evaluated whole-brain connectivity with these seeds. For
each participant, mean fMRI time courses (i.e., physio-
logical regressors) were extracted from seed regions for
each task run using fslmeants in FSL, then multiplied by
each psychological regressor of interest (i.e., Trial Type:
reward, non-reward) to form the PPI interaction terms.
The gPPI model included physiological and psycho-
logical regressors, as well as their interaction terms to
describe the unique effect of these interactions above
and beyond the main effect of seed time courses and
reward conditions. Our contrasts of interest evaluated
the reward condition alone. No additional preprocessing
procedures were completed beyond what has been
described above. Supplemental analyses examined func-
tional connectivity with anatomically defined right and
left NAcc using the same procedures described for the
functional connectivity analyses (see Additional file 1:
Supplementary Materials).
Symptom analyses
Symptom analyses examined interactions between ASD
symptom severity, measured by the Social Responsive-
ness Scale (SRS) [45], and functional activation and con-
nectivity in the OT relative to PLC condition, conducted
by including demeaned SRS values as a covariate within
frontostriatal general linear models within the ASD
group. Supplementary analyses examined interactions
between ASD symptoms and structural activation, as
well as functional activation of structurally defined
clusters (see Additional file 1: Supplementary Materials).
Salivary analyses
Saliva samples were collected using pediatric oral swabs
(Salimetrics) prior to each nasal drug administration
(i.e., OT and PLC) and immediately following the fMRI
scan (time between samples in minutes M = 85; SD = 9).
During each sample, participants were asked to place
the swab under their tongue for approximately 1 min or
until it was saturated with saliva. Samples were stored
on ice for up to 2 h to liquid extraction and were per-
manently stored at − 70 °C (see Additional file 1:
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Supplementary Materials for a more detailed description
of the salivary analyses).
Results
Face image ratings
Participants rated the faces seen in the social reward
condition on the dimensions of valence, arousal, and
trust prior to and immediately following each scan.
Results from a 2 (Treatment Group: OT, PLC) × 2
(Time point: pre- or post-scan) ANOVA revealed a main
effect of time point for the dimension of trust, such that
participants were more likely to rate the faces as more
trustworthy at the post-scan rating (M = 5.07; SD = 1.59)
compared to the pre-scan rating (M = 4.86; SD = 1.63),
regardless of treatment condition, F(1,54) = 8.37, p = .006
(see Fig. 1). Additionally, a main effect of time point for
the dimension of arousal was observed, reflecting that
participants perceived the faces at the post-scan rating
(M = 5.04; SD = 1.75) to be more arousing than those at
the pre-scan rating (M = 4.91; SD = 1.80) across treat-
ment groups, F(1,54) = 4.42, p = .040. No other main ef-
fects or interactions between treatment group and time
point for the perceived valence, arousal, or trust of the
faces were significant, all p values > .05.
Task reaction times
Reaction times (RTs) to task bull’s-eyes are depicted in
Fig. 2 and were evaluated via a 2 (Treatment Group: OT,
PLC) × 2 (Reward Condition: nonsocial, social) × 2 (Trial
Type: reward, non-reward) mixed ANOVA. There was a
main effect for trial type, F(1,54) = 18.67, p < .0001, such
that individuals responded more quickly to trials during
which they could receive a reward (M = 226.49; SD = 59.73)
compared to trials in which they could not receive a reward
(M = 242.03; SD = 60.91). No other main effects or interac-
tions between treatment group, reward condition, and trial
type were significant, all p values > .05.
Functional activation analyses
Nonsocial reward
During nonsocial reward anticipation, there were no re-
gions with relatively decreased activation in the OT rela-
tive to the PLC condition. However, there were several
clusters with greater activation during nonsocial reward
anticipation in the OT condition relative to PLC, includ-
ing the right NAcc, right frontal pole (FP), left ACC, left
superior frontal cortex, and bilateral orbital frontal cor-
tex (OFC) (see Fig. 3 and Table 2).1 Significant increases
in activation were observed during nonsocial reward
outcomes after OT relative to PLC administration in the
right OFC and left FP (see Fig. 4).
Supplementary analyses for OT and PLC conditions
separately are presented in Additional file 1: Supple-
mentary Materials and visualized within Additional
file 2: Figure S1 and Additional file 3: Figure S2.
These simple effects analyses revealed that both
groups showed activation in mesocorticolimbic reward
processing regions in response to the social and non-
social incentive delay tasks.
Social reward
During social reward outcomes, there was significantly
decreased activation in the right frontal pole in the OT
condition relative to the PLC condition. There were no
other clusters with significant changes in activation
during social anticipation or social outcomes in the OT con-
dition relative to the PLC condition (see Additional file 1:
Supplementary Materials and Additional file 4: Figure S3 for
structural activation results for social and nonsocial reward
anticipatory and outcomes).
Treatment Group × Reward Condition Interaction
We next evaluated the impact of OT, relative to PLC, on
nonsocial versus social reward processing by evaluating
a Treatment Group × Reward Condition interaction
general linear model. OT increased activation in the
Fig. 1 Subjective ratings of faces. Average ratings of valence, arousal,
and trust of faces. Valence = 0 (extremely unpleasant) to 8 (extremely
pleasant); arousal = 0 (not at all aroused) to 8 (extremely aroused); trust
= 0 (not at all trustworthy) to 8 (extremely trustworthy). *p < .05
Fig. 2 fMRI task reaction times. Mean reaction times of reward and
non-reward trials during the social and nonsocial reward
tasks. *p < .05
Greene et al. Journal of Neurodevelopmental Disorders  (2018) 10:12 Page 6 of 16
right caudate nucleus, left ACC, bilateral FP, right insu-
lar cortex, and right OFC in response to nonsocial com-
pared to social reward outcomes (see Table 2). Planned
analyses within the striatal small volume revealed greater
activation during nonsocial relative to social reward an-
ticipation after intranasal OT relative to PLC in the right
NAcc. There were no regions with greater activation
during social relative to nonsocial reward anticipation or
outcomes after intranasal OT relative to PLC.
Correlations between functional activation and ASD
symptoms
Increased ASD symptom severity, as measured by SRS
total scores, was associated with greater activation in the
right FP and the right ACC during nonsocial reward an-
ticipation and greater activation in the right precentral
gyrus and left caudate nucleus during nonsocial reward
outcome following the administration of OT relative to
PLC (see Fig. 5 and Table 3). This finding within the left
caudate nucleus was corroborated by structural activa-
tion analyses (see Additional file 1: Supplementary Mate-
rials). There were no relations between symptom
severity and brain activation in the anticipation or out-
come phases of the social reward condition.
Functional connectivity analyses
Given the prominent roles of the NAcc and ACC in re-
ward processing [46, 47], functional connectivity ana-
lyses were seeded by the right NAcc and left ACC
functional clusters that showed increased activation to
OT relative to PLC during nonsocial reward anticipation
in the functional activation analyses. Because there were
no clusters that differentiated conditions in the social
reward condition, functional connectivity results are
only reported for connectivity in the nonsocial reward
condition (functional connectivity of structurally defined
clusters is presented in Additional file 1: Supplementary
Materials).
Right nucleus accumbens seed
During nonsocial reward anticipation, OT relative to
PLC administration resulted in increased functional con-
nectivity between the right NAcc seed and the right
frontal pole (see Fig. 6), whereas OT-induced decreases
in functional connectivity were observed between the
right NAcc seed and the left precentral gyrus and the
right superior frontal gyrus (see Table 4). These findings
were further corroborated by functional connectivity
analyses of structurally defined clusters using a struc-
tural right NAcc seed (see Additional file 1: Supplemen-
tary Materials and Additional file 5: Figure S4). During
nonsocial reward outcomes, increased functional con-
nectivity was observed between the right NAcc and the
right OFC and left FP in response to OT relative to
PLC. Finally, decreased functional connectivity was ex-
hibited between the right NAcc and right postcentral
gyrus during nonsocial reward outcomes following OT
administration relative to PLC.
Anterior cingulate cortex seed
During the anticipation of nonsocial rewards, there was
decreased functional connectivity between the left ACC
and the left precentral gyrus, the right frontal pole, and
the right superior frontal gyrus after OT relative to PLC.
Attenuated functional connectivity with the left ACC was
also observed with bilateral postcentral gyrus, the left in-
ferior frontal gyrus, the left precentral gyrus, and the left
medial frontal gyrus during nonsocial reward outcomes
following OT relative to PLC (Table 5). No increases in
connectivity were exhibited with the left ACC for nonso-
cial reward anticipation or outcomes, all p values > .05.
Fig. 3 Differential functional activation after OT relative to PLC administration during nonsocial reward anticipation. Brain areas with greater
activation during nonsocial reward anticipation after intranasal OT administration relative to PLC administration include the right nucleus
accumbens (left), the right orbital frontal cortex (center), and the left anterior cingulate cortex (right)
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Correlations between functional connectivity and ASD
symptoms
For the right NAcc and left ACC seeds, greater ASD
symptom severity, measured by SRS total scores, was as-
sociated with increased connectivity with the right post-
central gyrus during nonsocial reward outcomes
following OT relative to PLC (see Table 6). During non-
social reward anticipation, there were no significant cor-
relations between SRS scores and connectivity with the
right NAcc or left ACC following OT relative to PLC.
Salivary OT
To examine changes in OT concentration levels, salivary
samples were collected prior to OT administration and
immediately following the fMRI scan. There were
considerable individual differences in the magnitude of
salivary OT change from baseline to post-scan following
OT administration, and, thus, one outlier was removed
from salivary analyses due to significantly elevated OT
concentration levels (754.17 pg/ml) in the PLC condition.
After the removal of this outlier, as expected, there was a
significant increase in mean peripheral OT levels follow-
ing OT administration relative to PLC, t = 3.57; p = 0.0016
(see Fig. 7).
Because of the primary role of the NAcc in reward
processing [46], correlation analyses examined relations
between changes in peripheral OT and neural activation
within the right NAcc functional activation cluster iden-
tified in the nonsocial anticipation activation analysis.
This revealed a significant positive correlation indicating
Fig. 5 Correlations between SRS and differences in functional activation after OT vs. PLC during nonsocial reward anticipation. The right frontal
pole, left putamen, and left anterior cingulate cortex showed increased activation in individuals with greater ASD symptoms during nonsocial
reward anticipation following OT relative to PLC administration
Fig. 4 Differences in functional activation after OT relative to PLC administration during nonsocial reward outcomes. Brain areas with greater
activation during nonsocial reward outcome after intranasal OT administration relative to PLC administration include the left frontal pole (left) and
the right orbital frontal cortex (right)
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that individuals with greater changes in peripheral OT
concentrations following OT administration showed
greater increased activation within the right NAcc
functional activation cluster during nonsocial reward an-
ticipation, r = 0.56; p = 0.005 (see Fig. 8). However, when
a significant outlier (2 SD’s > the salivary group mean; 3
SD’s > the activation group mean) was removed, the re-
lation was no longer significant, r = 0.26; p = 0.23.2
Discussion
The purpose of this investigation was to examine the ef-
fects of acute intranasal OT administration on functional
activation and connectivity within mesocorticolimbic brain
regions during the anticipation and receipt of social and
nonsocial rewards in ASD. OT administration, relative to
PLC administration, was associated with increased activity
in the right NAcc, the right FP, the left ACC, the left super-
ior frontal cortex, and bilateral OFC during anticipation of
nonsocial rewards. These findings combined with prior
ASD research demonstrating increased activation in the
NAcc following OT administration during a social judg-
ment task [22] suggest that whether OT impacts social or
nonsocial processing is contingent on task context. In
addition, the correlation between salivary OT concentra-
tions and changes in right NAcc activation indicates that
this region may be particularly sensitive to the acute effects
of OT (though this correlation was not significant following
removal of an outlier). This is consistent with preclinical
findings, which indicate that the NAcc is among several
neural regions with the highest OT receptor density [48].
Although we found increased left ACC activation after
OT administration during nonsocial reward anticipation,
Watanabe and colleagues [49] reported increased ACC
activation after OT administration during a social judg-
ment task, reflecting the task-dependent nature of the
effects of OT on neural responses to social or nonsocial
processing. Our finding of increased activation of OFC,
a region with an established role in reward processes
documented in preclinical and clinical studies [50, 51],
during the anticipation and receipt of nonsocial rewards
after OT administration is consistent with prior findings
that ASD is characterized by attenuated OFC activation
during nonsocial reward anticipation [26] and suggests a
remediation of this pattern in ASD after OT.
In contrast to previous studies examining the neural im-
pact of OT in response to social stimuli in individuals with
ASD [22, 23], we did not find evidence of increased activity
in mesocorticolimbic regions during social reward process-
ing following OT administration. Further, interaction
analyses showed increased activity in the right nucleus
accumbens and right caudate nucleus during nonsocial re-
ward anticipation relative to social reward anticipation. The
lack of effects of OT in the social reward conditions are
surprising and stand in contrast to preclinical findings that
OT enhances neural responses to a range of social stimuli,
including conditioned social preference [52–54] and repro-
ductive behaviors [55, 56] as well of the prosocial effects of
OT in ASD [57]. These unexpected findings highlight that
OT may serve to increase neural activations in response to
nonsocial rewards. These effects are consistent with pre-
clinical findings that the impact of OT is apparent in the
context of a certain nonsocial rewards, including food cues
[58, 59] and place preferences [60, 61], and it may be the
Fig. 6 Functional connectivity during nonsocial reward anticipation
with the functionally defined right nucleus accumbens seed. The
right frontal pole (red) shows greater functional connectivity with
the right NAcc (white) during nonsocial reward anticipation after
intranasal OT administration relative to PLC administration
Table 3 Correlations between ASD symptoms and functional activation to oxytocin relative to placebo
Phase Reward condition Region Hem k BA x y z Z max
Anticipation Nonsocial Frontal pole R 95 10 41 95 38 3.53
Anterior cingulate cortex L 82 32 46 83 46 3.41
Outcome Nonsocial Precentral gyrus R 48 – 18 59 51 3.29
Caudate nucleus L 51 – 58 63 47 3.27
Hem hemisphere, k cluster size in voxels, BA Brodmann area, Z max maximum z-value
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case that the clinical benefits of OT on social functioning
in ASD (e.g., enhanced emotion recognition and increased
eye gaze) reflect the influence of OT on mesocorticolimbic
reward processing systems that mediate nonsocial incentive
salience processing, reward valuation, and reward-based
learning [62] rather than responses specifically to social re-
wards. Alternatively, it may be the case that the static social
rewards used in this study impeded our capacity to detect
OT-related neural changes given that dynamic stimuli have
been shown to be more potent elicitors of social impair-
ments in ASD than static stimuli [63]. Future studies that
evaluate the impact of OT on neural responses to dynamic
social rewards will be needed to evaluate this possibility.
We observed significant correlations between ASD symp-
tom severity and increased activity within the right frontal
pole and the left ACC during nonsocial reward anticipation
in response to OT relative to PLC. Additionally, during
nonsocial reward outcomes, increases in the left caudate
nucleus and right precentral gyrus activity after OT relative
to PLC were significantly correlated with symptom severity.
The postcentral gyrus also showed greater connectivity with
both the right NAcc and left ACC functional seeds as ASD
symptom severity increased. These regions may be most
responsive to neural effects of OTadministration in individ-
uals with more severe ASD presentations. Alternatively,
these associations suggest that the impact of OT on re-
sponses to nonsocial rewards may be conditional on ASD
symptom severity. These associations may also reflect
mechanisms described by Parker and colleagues [15] which
revealed that individuals with ASD with lower endogenous
levels of OT benefited the most from OT. Thus, it may be
the case that individuals with greater ASD symptoms dem-
onstrated greater regional activation changes during reward
anticipation in response to OT. It is noteworthy that symp-
tom correlations with neural responses to nonsocial reward
anticipation were apparent in brain regions (FP and ACC)
implicated in higher-order executive processing [64] and
known to show functional impairments in ASD in the con-
text of cognitive control tasks [65, 66]. Conversely, regions
showing symptom correlations with neural responses to so-
cial reward anticipation involved regions implicated in
other functioning, including imitation (precentral gyrus
[67]) and learning (the caudate nucleus [68]), though the
replicability of these patterns is not yet known.
OT administration was associated broadly with decreased
connectivity with functional seeds. Decreased connectivity
was observed between the right NAcc and the left precen-
tral gyrus and the right superior frontal gyrus during the an-
ticipation of nonsocial rewards as well as with the
postcentral gyrus during nonsocial reward outcomes
Table 5 Functional connectivity with the left ACC seed
Phase Reward condition Region Hem k BA x y z Z max
OT < PLC
Anticipation Nonsocial Precentral gyrus L 206 – 58 58 63 3.86
Frontal pole R 197 – 30 83 48 3.34
Superior frontal gyrus R 39 – 37 63 69 3.66
Outcome Postcentral gyrus R 179 – 21 57 51 3.72
L 90 3 75 57 50 3.13
Inferior frontal gyrus L 55 – 70 78 42 3.64
Precentral gyrus L 49 – 73 64 54 3.13
Medial frontal gyrus L 42 6 57 66 59 3.09
Hem hemisphere, k cluster size in voxels, BA Brodmann area, Z max maximum z-value
Table 4 Functional connectivity with the right NAcc seed
Phase Reward condition Region Hem k BA x y z Z max
OT > PLC
Anticipation Nonsocial Frontal pole R 45 – 39 95 39 3.39
Outcome Orbital frontal cortex R 82 – 22 75 31 3.96
Frontal pole L 41 9 54 92 52 3.19
OT < PLC
Anticipation Nonsocial Precentral gyrus L 266 – 54 62 63 3.64
Superior frontal gyrus R 53 – 37 63 69 3.6
Outcome Postcentral gyrus R 42 – 19 58 51 3.4
Hem hemisphere, k cluster size in voxels, BA Brodmann area, Z max maximum z-value
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following OT administration relative to PLC. Further, OT-
induced attenuation in functional connectivity was observed
between the left ACC functional seed and the left precentral
gyrus, the right frontal pole, and the right superior frontal
gyrus during nonsocial reward anticipation. During nonso-
cial reward outcomes, decreased functional connectivity
was observed between the left ACC and bilateral postcentral
gyrus, left inferior frontal gyrus, left precentral gyrus, and
left medial frontal gyrus following OT relative to PLC. Rest-
ing state functional connectivity findings suggest that ASD
is largely characterized by increased frontostriatal
connectivity relative to typically developing controls [69–
72], and the results of the present study suggest that OT
may normalize these increased frontostriatal functional
connections.
There were additional findings of increased functional
connectivity after OT administration, including in-
creased connectivity between the right NAcc and the
right FP during nonsocial reward anticipation. OT-
induced increased connectivity between the right NAcc
and right FP was also reported by Gordon et al. [23]
using a biological motion task. This finding across two
different task contexts highlights a neural pathway by
which OT may exert a therapeutic effect by potentiating
neural connectivity. The FP plays a critical role in the cog-
nitive processing of future events [73], a process that may
a
c
b
Fig. 7 Salivary OT concentrations. Change in log-transformed salivary OT levels (pg/ml) for 24 participants (minutes between samples M = 85;
SD = 9). Four participants were unable to provide adequate saliva samples and were not included in the salivary analyses. a Change in salivary OT
following nasal OT administration. b Change in salivary OT following nasal-PLC administration. Because participant 10 was a significant outlier
(change in OT concentration after PLC = − 723.59), their data are not included in the graph above. c *p < .05. Salivary samples collected after OT
administration showed significantly greater OT concentrations compared to those following the PLC nasal spray, t = 3. 57; p = 0.0016
Table 6 Correlations between ASD symptoms and functional connectivity for oxytocin relative to placebo
Phase Reward condition Region Hem k BA x y z Z max
Right NAcc seed
Outcome Nonsocial Postcentral gyrus R 74 – 18 58 51 3.37
Left ACC seed
Outcome Nonsocial Postcentral gyrus R 131 – 18 58 51 3.5
Hem hemisphere, k cluster size in voxels, BA Brodmann area, Z max maximum z-value
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be particularly relevant to reward contexts. Additionally,
the right NAcc demonstrated relatively greater connectivity
with the right FP and right OFC during nonsocial reward
outcomes following OT administration relative to PLC,
though the directionality of this effect was unexpected
given that increased functional connectivity between the
striatum and the OFC has been reported in ASD during
resting-state functional connectivity [69]. It is also note-
worthy that the effects of OT on the NAcc and ACC exhib-
ited right-lateralized effects given evidence of right
lateralization of functional neural responses to social and
nonsocial stimuli in ASD [74, 75], though it should be
noted that incentive delay tasks do not reliably evoke
greater activation in one hemisphere or the other but rather
tend to evoke bilateral reward-related frontostriatal activa-
tions [76].
Ratings of faces in the social task revealed a significant
increase in ratings of trustworthiness and arousal for
faces following the scan. These main effects were not
moderated by treatment group (i.e., OT, PLC), indicating
that individuals rated faces they had seen previously as
more trustworthy across both treatment groups.
Previous studies have reported that individuals with
ASD reliably understand the concept of trustworthiness
and distinguish trustworthy versus non-trustworthy faces
[77, 78]. Our results suggest that familiarity with faces
may increase ratings of trustworthiness and arousal for
individuals with ASD. No effects were observed for rat-
ings of valence.
Task reaction times showed increased speed of re-
sponses to reward relative to non-reward trials, with no
significant interactions of treatment group (OT, PLC) or
Reward Type (nonsocial, social). These findings are con-
sistent with reports of decreased reaction times for re-
ward compared to non-reward trial in ASD [79].
Delmonte and colleagues [79] reported no relation
between reward condition (e.g., nonsocial vs. social) and
reaction times. However, this stands in contrast with
other ASD reward studies that have reported faster reac-
tion times in response to nonsocial rewards compared to
social rewards [26, 80]. This discrepancy may reflect dif-
ferent ages of participants across studies: the current
study and others showing no differences in reaction
times based on reward condition were conducted in
child and adolescent populations, whereas those showing
faster responses for nonsocial versus social rewards were
completed using adult participants. This may suggest
that during development, nonsocial rewards may begin
to have increased salience relative to social rewards in
individuals with ASD. This might be related to increased
awareness of the relationship between money and
acquiring objects of interest and/or to increased
demands in financial responsibility for adults living inde-
pendently. This developmental interaction should be
noted in future studies examining differential responses
to nonsocial versus social rewards in ASD. It may also
be useful to explore the salience of other nonsocial re-
wards in ASD.
In addition to the substantive findings reported here,
these results have implications for future experimental
therapeutic trials that seek to evaluate novel ASD thera-
peutics. The National Institute of Health has emphasized
the use of translational research to speed the discovery
of treatments through pipelines that evaluate the poten-
tial for novel compounds to engage brain targets
relevant to disease etiology [81]. In addition to providing
substantive results about the neural impact of acute in-
tranasal OT administration on reward processing brain
systems, the present study also suggests that optimal
approaches to evaluate novel ASD treatments with puta-
tive effects on brain systems that support social reward
processing may not be constrained to evaluating re-
sponses to only social stimuli. Rather, novel pro-social
ASD therapeutics may exert their influence on relevant
brain targets in a range of social and/or nonsocial con-
texts. In this regard, these results provide preliminary
data to guide the development of optimal targets for use
in future experimental therapeutics trials that evaluate
novel ASD social communication treatments.
The present study had some limitations. Developmen-
tal stage plays a particularly important moderating role
in the strength of functional connectivity patterns in
individuals with ASD, with younger individuals showing
increased connectivity compared to adolescents and
adults with ASD [82]. Future studies with large sample
sizes will be needed to examine the moderating effect of
developmental stage on the effects of OT on brain
activation and connectivity in ASD. Additionally, the
effects of prolonged OT administration are likely to be
distinct from the effects of a single dose, and future
Fig. 8 Correlations between OT-related neural activation and OT
salivary concentration changes following OT administration. Correlation
between mean percent signal change in the right NAcc functional
activation cluster during the anticipatory phase of the nonsocial reward
condition and change in peripheral OT levels following
OT administration
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research should examine the effect of chronic OT ad-
ministration on neural functioning in ASD. Additionally,
the order of social and nonsocial runs was not random-
ized across participants in this study. Because the
current study found no behavioral changes due to a sin-
gle OT administration, interpretations regarding associa-
tions between behavioral and neural effects of OT must
be cautious. Finally, because all participants in the
present study met a minimum IQ cutoff of 70, findings
from this study may be restricted to individuals with
ASD with higher cognitive ability.
Conclusions
Despite these limitations, these findings indicate a mech-
anistic role for the mesocorticolimbic system in the po-
tentially therapeutic effect of oxytocin in individuals
with ASD. These findings align with prior studies that
highlight the important role of enhanced functioning of
striatal regions as a potential mechanism of action of
OT [22, 23] and extend this area of research into the do-
main of striatal functioning in response to reward-based
tasks. When the present findings are considered along
with these prior fMRI studies, it appears that the role of
the mesocorticolimbic system in the effects of OT on
neural functioning is not confined to social rewards but
may extend to nonsocial responses more broadly, de-
pending on task contexts.
Endnotes
1Similar analyses during the anticipation of nonsocial
rewards were conducted after removing both female par-
ticipants, as well as a participant with outlying salivary
OT concentrations (see Figure 7a). Results from these
analyses remained statistically significant within all re-
gions reported in Table 2. Therefore, all activation re-
sults include both females and the participant with
outlying salivary OT levels.
2We thank an anonymous reviewer for highlighting
this. This outlier was not the same outlier as the one
mentioned in the previous salivary analyses examining
treatment group (OT vs. PLC) differences in OT
concentrations.
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